Tamoxifen induces regression of estradiol-induced mammary cancer in the ACI.COP-Ept2 rat model
- 9 September 2008
- journal article
- research article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 117 (3) , 517-524
- https://doi.org/10.1007/s10549-008-0169-0
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Tissue-Specific Actions of the Ept1, Ept2, Ept6, and Ept9 Genetic Determinants of Responsiveness to Estrogens in the Female RatEndocrinology, 2008
- Both ovarian hormones estrogen and progesterone are necessary for hormonal mammary carcinogenesis in ovariectomized ACI ratsProceedings of the National Academy of Sciences, 2008
- Genome-wide association study identifies novel breast cancer susceptibility lociNature, 2007
- Estrogen Carcinogenesis in Breast CancerNew England Journal of Medicine, 2006
- Registration of [18F]FDG microPET and small-animal MRINuclear Medicine and Biology, 2005
- Genetic Determination of Susceptibility to Estrogen-Induced Mammary Cancer in the ACI RatGenetics, 2004
- Breast cancer and hormone-replacement therapy in the Million Women StudyThe Lancet, 2003
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled TrialJAMA, 2002
- Ploidy differences between hormone‐ and chemical carcinogen–induced rat mammary neoplasms: Comparison to invasive human ductal breast cancer*Molecular Carcinogenesis, 2002
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu OncogeneScience, 1987